Michael E. Franklin

681 total citations
14 papers, 543 citations indexed

About

Michael E. Franklin is a scholar working on Transplantation, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael E. Franklin has authored 14 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 4 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Michael E. Franklin's work include Renal Transplantation Outcomes and Treatments (6 papers), HIV/AIDS drug development and treatment (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). Michael E. Franklin is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), HIV/AIDS drug development and treatment (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). Michael E. Franklin collaborates with scholars based in Australia, Denmark and United Kingdom. Michael E. Franklin's co-authors include Paul J. Taylor, Peter I. Pillans, Graeme A. Macdonald, Carl M. J. Kirkpatrick, Gethin Thomas, Jennifer Martin, Maree Ferguson, Johannes B. Prins, Ingrid J. Hickman and Veronique Chachay and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Clinical Gastroenterology and Hepatology and Journal of Chromatography B.

In The Last Decade

Michael E. Franklin

14 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Franklin Australia 11 175 117 108 106 86 14 543
Álvaro Cerda Brazil 17 85 0.5× 16 0.1× 64 0.6× 55 0.5× 204 2.4× 58 704
Arno J. Arranto Finland 13 183 1.0× 29 0.2× 60 0.6× 19 0.2× 117 1.4× 25 791
M.C. Pastor Spain 13 40 0.2× 14 0.1× 61 0.6× 19 0.2× 67 0.8× 26 482
Kaoru Ueda Japan 11 62 0.4× 19 0.2× 69 0.6× 9 0.1× 91 1.1× 33 760
Kari T Kivist Germany 8 160 0.9× 11 0.1× 24 0.2× 17 0.2× 139 1.6× 8 861
Sandra Bodeau France 13 100 0.6× 19 0.2× 38 0.4× 5 0.0× 196 2.3× 50 560
J. Carlos Tutor Spain 16 118 0.7× 6 0.1× 163 1.5× 96 0.9× 189 2.2× 67 781
F J Frey Switzerland 14 36 0.2× 6 0.1× 59 0.5× 64 0.6× 79 0.9× 28 589
Alison E. Aitken United States 6 97 0.6× 7 0.1× 39 0.4× 13 0.1× 160 1.9× 6 767
Maobai Liu China 17 96 0.5× 10 0.1× 25 0.2× 5 0.0× 125 1.5× 87 815

Countries citing papers authored by Michael E. Franklin

Since Specialization
Citations

This map shows the geographic impact of Michael E. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Franklin more than expected).

Fields of papers citing papers by Michael E. Franklin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Franklin. The network helps show where Michael E. Franklin may publish in the future.

Co-authorship network of co-authors of Michael E. Franklin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Franklin. A scholar is included among the top collaborators of Michael E. Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Franklin. Michael E. Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rand, Jacquie, et al.. (2023). Attitudes and Beliefs of a Sample of Australian Dog and Cat Owners towards Pet Confinement. Animals. 13(6). 1067–1067. 6 indexed citations
2.
Franklin, Michael E., Jacquie Rand, Linda C. Marston, & John M. Morton. (2021). Do Pet Cats Deserve the Disproportionate Blame for Wildlife Predation Compared to Pet Dogs?. Frontiers in Veterinary Science. 8. 731689–731689. 4 indexed citations
3.
Jung, Ji‐Won, Jennifer A. Bridge, Nana Haahr Overgaard, et al.. (2018). Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma. OncoImmunology. 7(9). e1479627–e1479627. 30 indexed citations
4.
Chachay, Veronique, Graeme A. Macdonald, Jennifer Martin, et al.. (2014). Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 12(12). 2092–2103.e6. 244 indexed citations
5.
Tan, Terrence, Dorothy H. Crawford, Michael E. Franklin, et al.. (2012). The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver International. 32(9). 1391–1399. 55 indexed citations
6.
Taylor, Paul J., et al.. (2011). Therapeutic drug monitoring of tacrolimus by liquid chromatography–tandem mass spectrometry: Is it truly a routine test?. Journal of Chromatography B. 883-884. 108–112. 24 indexed citations
7.
Napoli, Kimberly L., Catherine A. Hammett‐Stabler, Paul J. Taylor, et al.. (2010). Multi-center evaluation of a commercial Kit for tacrolimus determination by LC/MS/MS. Clinical Biochemistry. 43(10-11). 910–920. 29 indexed citations
8.
Stocker, Sophie L., Michael E. Franklin, John E. Anderson, et al.. (2010). Measurement of urinary oxypurinol by high performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 878(25). 2363–2368. 11 indexed citations
9.
Barraclough, Katherine A., Nicole M. Isbel, Michael E. Franklin, et al.. (2010). Evaluation of Limited Sampling Strategies for Mycophenolic Acid After Mycophenolate Mofetil Intake in Adult Kidney Transplant Recipients. Therapeutic Drug Monitoring. 32(6). 723–733. 27 indexed citations
10.
11.
12.
Franklin, Michael E., Nigel W. Brown, J. Michael Tredger, et al.. (2007). The measurement of total and free mycophenolic acid by HPLC-Tandem mass spectrometry. Therapeutic Drug Monitoring. 29(4). 510–511. 1 indexed citations
13.
Taylor, Paul J., Michael E. Franklin, Kendon S. Graham, & Peter I. Pillans. (2006). A HPLC–mass spectrometric method suitable for the therapeutic drug monitoring of everolimus. Journal of Chromatography B. 848(2). 208–214. 23 indexed citations
14.
Dickinson, R. G., et al.. (1991). Facile Hydrolysis of Mebeverine In Vitro and In Vivo: Negligible Circulating Concentrations of the Drug after Oral Administration. Journal of Pharmaceutical Sciences. 80(10). 952–957. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Álvaro Cerda Breakdown of academic impact, for papers by Arno J. Arranto Breakdown of academic impact, for papers by M.C. Pastor Breakdown of academic impact, for papers by Kaoru Ueda Breakdown of academic impact, for papers by Kari T Kivist Breakdown of academic impact, for papers by Sandra Bodeau Breakdown of academic impact, for papers by J. Carlos Tutor Breakdown of academic impact, for papers by F J Frey Breakdown of academic impact, for papers by Alison E. Aitken Breakdown of academic impact, for papers by Maobai Liu
Rankless by CCL
2026